# Oxalo Therapeutics, Inc. — Form D

Oxalo Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-06. $250K was reported sold. Industry: Other Technology.

## Offering

- Filed: 2018-06-06
- Form: D
- Accession: 0001740010-18-000002
- Industry: Other Technology
- Exemptions: 06b
- Amount sold: $250K
- Minimum investment: $1
- Investors: 1
- Date of first sale: 2018-06-05
- Revenue range: Decline to Disclose
- SEC file number: 021-313980

## Issuer

- Name: Oxalo Therapeutics, Inc.
- CIK: 0001739172
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1452 EAST 53RD STREET, CHICAGO, IL, 60615
- Phone: 312-906-5342

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Hatim Hassan | Director | Chicago, IL |
| Yang Zheng | Director | Chicago, IL |
| Hatim Hassan | Executive Officer | Chicago, IL |

## More

- [CIK 1739172 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739172&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001740010-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.